Sherry Taylor Ph.D. 1986-1990
The molecular analysis of mutations of the human factor IX gene
Currently: Director, Molecular Diagnostic Laboratory, St. John Hospital, New Brunswick

Elizabeth Murray M.Sc. 1987-1989
The genetics of von Willebrand's disease
Currently: Research Group Leader, Biotechnology Company, Calgary

David Picketts Ph.D. 1990-1993
Structure and function relationships of factor IX
Currently: Associate Professor, University of Ottawa

Elizabeth Murray Ph.D. 1989-1994
Molecular studies of the interactions of von Willebrand factor with platelet glycoprotein Ib
Currently: Research Group Leader, Biotechnology Company, Calgary

Lesley McGlynn M.Sc. 1992-1994
Transcriptional regulation of the Factor VIII gene
Currently: Senior supervisory molecular genetic technologist, Hospital for Sick Children

Lara Boccia M.Sc. 1992-1994
An analysis of the upstream promoter elements of the factor IX gene
Currently: Biotechnology Technologist

Susan Kerr M.Sc. 1991-1996
A molecular study of the platelet glycoprotein Ib/IX complex
Currently: Life Insurance Executive

Jolene Brady M.Sc. 1994-1996
The role of androgens and distal regulatory elements on expression of factor IX.
Currently: Physician

Kimberley Wynd M.Sc. 1996-1998
Receptor-mediated delivery of factor VIII transgenes to hepatocytes.
Currently: Physician

Kelly Wilton M.Sc. 1996-1998
Factors influencing the phenotype of hemophilia B Leyden.
Currently: High School Biology Teacher, London, ON

Carla Cuthbert Ph.D. 1994-2000
Megakaryocytic differentiation and von Willebrand factor expression
Currently: Clinical Chemist, Florida, USA

Angela Keightley Ph.D. 1995-2000
The control of endothelial cell expression of von Willebrand factor
Currently: Research Scientist, Montreal

Megan Begbie Ph.D. 1995-1999
Factors influencing transcriptional activation of the factor VIII and IX genes
Currently: Scientist, Health Canada, Ottawa, ON

Brian Brown Ph.D. 1998-2003
Evaluation of gene therapy strategies for hemophilia A
Currently: Assistant Professor, Mount Sinai Medical Centre, New York City, NY

Annie Killoran M.Sc. 1999-2001
Non-viral delivery of canine factor VIII transgenes for hemophilia gene therapy
Currently: Physician

Lee O’Brien Ph.D. 2000-2004
Factors influencing the biosynthetic efficiency of von Willebrand factor by endothelial cells
Currently: Research Scientist, Eli Lilly, USA

Fiona Rawle (nee Grant) Ph.D. 2000-2005
Immunologic responses to factor VIII gene therapy
Currently: Lecturer, McMaster University

Stephanie Van der Pol M.Sc. 2004-2005
Tolerance induction to FVIII through tolerogenic antigen presentation
Currently: Physiotherapist

Cyndi Pruss Ph.D. 2004-2010
The role of von Willebrand factor in arterial thrombosis

Mohammad Quadura Ph.D. 2005-2008
Induction of immunologic tolerance to factor VIII
Currently: Undergraduate Medical Student, McMaster University

Braden Waters Ph.D. 2006-2010
Mechanisms of immunologic tolerance to Factor VIII

Mia Golder Ph.D. 2006-2010
The role of Factor VIII and von Willebrand factor in arterial thrombosis

Jacob Riches M.Sc. 2009-2012
Endothelial cell differentiation and the synthesis of FVIII and VWF

Meghan Deforest M.Sc. 2011-2013
Generation and optimization of the Self-Administered Bleeding Assesment Tool

Mackenzie Bowman Ph.D. 2008-2013
Investigating the genetic basis of type 3 von Willebrand disease

Jane Young M.Sc. 2013-2015
Validation of the Self-BAT (Self-Administered Bleeding Assessment Tool) and evaluation of determinants of health in Hemophilia carriers

Lara Casey, M.Sc. 2013 - 2015
Investigating the dysregulation of angiogenesis in type 2 von Willebrand Disease (VWD) in blood outgrowth endothelial cells

Lindsey Hawke, Ph.D. 2010 - 2015
The Effect of Variant VWF Splicing on Quantitative and Qualitative Variants of VWD

Silvia Albanez Ph.D. 2010 - 2015
Evaluation of the age-related pathophysiology of von Willebrand factor

Jackie Leonard M.Sc. 2012 - 2016
The effect of biomechanical and biochemical regulators on the expression of Factor VIII and von Willebrand Factor in endothelial cells

Jesse Lai, PhD 2013-2017
Early mechanisms of FVIII immunity in Hemophilia A

Victoria Candy, MSc 2015-2017
Evaluation of the determinants and characterization of bleeding in Hemophilia A and B carriers


Seiki Kamisue PDF 1994-1996
Characterization of a canine model of hemophilia A
Currently: Faculty, Nara College of Medicine, Japan

Christine Hough PDF 1996-1998
Definition of a canine model of hemophilia A
Currently: Adjunct Assistant Professor, Queen’s University

Kirsty Tompkins PDF 1998-1999
The platelet adhesive genotype and unstable angina
Currently: Associate Professor, Department of Medicine, Memorial University

Maha Othman PDF 2001-2002 & 2003-2005
Genetic variability of the collagen binding domain of von Willebrand Factor
Currently: Lecturer, St. Lawrence College, Kingston

Paula James PDF 2002-2004
Molecular genetic basis of type 1 von Willebrand disease
Currently: Professor, Department of Medicine, Queen’s University

Masaru Shibata PDF 2002-2005
Development of a lentiviral-based system for hemophilia gene therapy.
Currently: Faculty, Department of Pediatrics, Nara College of Medicine, Japan

Ergul Berber PDF 2002-2005
Biosynthetic defects of von Willebrand factor
Currently: Assistant Professor, Halic University, Istanbul, Turkey

Hideto Matsui PDF 2005-2009
Stem cell-based gene therapy for hemophilia A
Currently: Faculty, Department of Pediatrics, Nara College of Medicine, Japan

Rouzbeh Chegeni PDF 2005-2008
Gene transfer for von Willebrand disease
Currently: Senior Clinical Scientist, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Margareth Ozello PDF 2006-2010
Ex vivo gene transfer for hemophilia A
Currently: Senior Clinical Hematologist, University of Campinas, Brazil

Yasuaki Shida PDF 2010-2013
The role of von Willebrand factor and ADAMTS13 in thrombosis and hemostasis
Currently: Assistant Professor, Department of Pediatrics, Nara Medical University, Japan

Kenichi Ogiwara PDF 2013 - 2015
Characterizing mechanisms that regulate FVIII pharmacokinetics and VWF-FVIII clearance
Currently: Faculty, Department of Pediatrics, Nara Medical University, Japan

Page Last Updated: 2017 September 15